# algovigilance

> Agent-first AI safety MCP surface. 3062 tools across 280 source-domain categories, MCP 2025-03-26 endpoint at /api/mcp, AEO-compliant per Osmani (2026-04-11). Designed for agent consumption — no marketing chrome, no human-targeted layout.

Pharmacovigilance for algorithms. The discipline of watching AI systems for emergent harm — drift, deception, distributional shift, recursive observer collapse. EU AI Act + FDA SaMD aligned. Every capability reachable via MCP at /api/mcp.

## Agent entry points

- [/api/mcp](/api/mcp) — MCP 2025-03-26 JSON-RPC endpoint. POST `tools/list` returns the full surface (3062 tools).
- [/tools](/tools) — category index (280 categories) · [.md](/tools.md)
- [/index.md](/index.md) — this page as token-efficient markdown
- [/llms.txt](/llms.txt) — AEO discovery sitemap
- [/AGENTS.md](/AGENTS.md) — Linux Foundation AGENTS.md spec, repo-level orientation
- [/agent-permissions.json](/agent-permissions.json) — declarative allow/deny + rate limits
- [/sitemap.md](/sitemap.md) — every URL on this site, grouped by category
- [/data/structured.json](/data/structured.json) — JSON-LD SoftwareApplication record
- [/data/webmcp.json](/data/webmcp.json) — WebMCP page-level advertisement
- [/robots.txt](/robots.txt) — crawl rules (AI bots welcomed)

## Top 12 categories

By tool count. See [/tools](/tools) for all 280 categories or [/sitemap.md](/sitemap.md) for every per-tool URL.

| Category | Tools | Sample |
| --- | ---: | --- |
| `microgram` | 969 | [`list-chains`](/tools/microgram__list-chains) |
| `pv-compute` | 45 | [`pv-axioms-domain-dashboard`](/tools/pv-compute__pv-axioms-domain-dashboard) |
| `body-systems` | 40 | [`cardio-blood-health`](/tools/body-systems__cardio-blood-health) |
| `devtools` | 40 | [`analyze-patterns`](/tools/devtools__analyze-patterns) |
| `stem` | 38 | [`stem-bio-behavior-profile`](/tools/stem__stem-bio-behavior-profile) |
| `observatory` | 32 | [`viz-ae-overlay`](/tools/observatory__viz-ae-overlay) |
| `skills` | 24 | [`skill-categories-compute-intensive`](/tools/skills__skill-categories-compute-intensive) |
| `molecular-biology` | 23 | [`chemotaxis-gradient`](/tools/molecular-biology__chemotaxis-gradient) |
| `science` | 22 | [`compute-target-score`](/tools/science__compute-target-score) |
| `vigil` | 21 | [`vigil-authority-config`](/tools/vigil__vigil-authority-config) |
| `forge` | 20 | [`forge-atomize`](/tools/forge__forge-atomize) |
| `gcloud` | 19 | [`gcloud-auth-list`](/tools/gcloud__gcloud-auth-list) |

## MCP quick-connect

```json
{
  "mcpServers": {
    "algovigilance": { "url": "https://algovigilance.com/api/mcp" }
  }
}
```

## Example call

```json
POST /api/mcp
Content-Type: application/json

{
  "jsonrpc": "2.0",
  "id": 1,
  "method": "tools/call",
  "params": {
    "name": "station__algovigilance__triage-decay",
    "arguments": {
      "drug": "ozempic",
      "event": "thyroid c-cell hyperplasia",
      "half_life_days": 30
    }
  }
}
```

## Failure modes the surface monitors

- **Drift** — production model changes that quietly degrade behavior (data shifts, fine-tuning, upstream API rotations).
- **Recursive observer collapse** — when the system being monitored is also the monitor. Governance pattern: IAIR / ACA / QPAV (independent audit, change attestation, quantified post-deploy vigilance).
- **Emergent harm** — capabilities below training thresholds that materialize after deployment. Each release treated like a drug approval — measurable, reportable, recallable.

## Compliance frameworks

- **EU AI Act** — Article 9 risk management, Article 15 accuracy, Article 72 post-market monitoring
- **FDA SaMD** — IMDRF SaMD risk categorization, GMLP guidance
- **ISO 42001** — AI management system, audit-ready
- **NIST AI RMF** — Map, Measure, Manage, Govern

## Contact

algovigilance@gmail.com — partnerships, licensing, abuse reports.

## Status

Pre-launch preview. DNS for algovigilance.com pending. Infrastructure: mcp.nexvigilant.com (Station MCP server proxied for execution). Source: standalone Next.js project at `~/Projects/Active/algovigilance`.